CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on enhancing cancer treatment by designing new DNA-damaging drugs that create irreversible lesions in cancer cells. Using computational chemistry, it evaluates the structures and effects of these drugs, aiming to improve their therapeutic efficacy through advanced molecular modeling techniques.
Administration of DNA-damaging reagents constitutes one of the most effective chemotherapeutic strategies for the cancer treatment.
The families of drugs developed over the years for this purpose are based on second-order nucleophilic substitution (SN2) reactions.
Innovative candidates to improve the therapeutic action of these compounds have been designed based on increasing the number of electrophilic positions (En) of the reagent by making n>2.
This increased electrophilicity must generate in…
UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
